阶段角度作为多病症老年患者死亡率的预测指标:一个匹配的病例控制研究
Yao Wang1, Tingting Liu1, Tianru Zheng1
1Elderly Demonstration Ward, Beijing Geriatric Hospital, Beijing, China.
PeerJ
|December 2, 2024
概括
阶段角 (PhA) 是一个有价值的预后标志物,用于多种健康状况的老年患者的死亡率. 较低的PhA水平表明该人群的死亡风险更高.
科学领域:
- 老年学是一门学科.
- 临床营养学 临床营养学
- 生物统计学 生物统计学
背景情况:
- 患有多种疾病的老年患者面临着显著的死亡风险.
- 预后标记对于评估这一人口群体的生存率至关重要.
- 阶段角 (PhA) 是体细胞质量和流体状态的测量.
研究的目的:
- 为了评估相角 (PhA) 对老年患者多发病率的死亡率的预后值.
- 在这个人群中确定1年死亡率的独立风险因素.
主要方法:
- 采用了一种匹配的病例控制研究设计.
- 包括70岁以上多病症患者.
- 测量了身体成分 (包括PHA) 和血液学指数.
- 使用多变量逻辑回归和ROC曲线分析.
主要成果:
- 与幸存者相比,已故患者的相位角度 (PhA) 显着较低.
- PhA被确定为死亡率的唯一独立预测因子 (OR = 3.296).
- 在ROC分析中,PhA的预测性表现良好 (AUC=0.854).
结论:
- 阶段角度 (PhA) 是一个可靠的预后标志物,用于老年患者的死亡率与多病症.
- PhA测量可以帮助风险分层和临床决策.
相关概念视频
Actuarial Approach
63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Kaplan-Meier Approach
98
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
98


